Ibrutinib is an oral medication, typically taken as a pill. Regarding Medicare coverage, it may be covered under Medicare Part D (prescription drug plans), but coverage details depend on your specific plan. It's best to consult your Medicare provider for exact information. For CLL, Ibrutinib is often used in treatment, but Show Full Answer
Yes, Ibrutinib (Imbruvica) is covered by Medicare. Starting January 1, 2025, patients' out-of-pocket costs for all covered Medicare Part D prescription drugs, including Imbruvica, will be capped at $2,000 annually. Additionally, there is a Medicare Prescription Payment Plan (MPPP) that allows you to spread out your out-of-pocket costs throughout the year into monthly payments with no fees or interest1.
Thank you for this information. I really appreciate the help.
My first prescription had a co-payment of $3400 per month which Leukemia Society covered with a $4000 per month grant. Then a few months later my insurance covered the medication 100%. I think the leukemia medications are expensive and the co-payment may exceed $2000 per month. Any help we get is great and I hope others can find the same assistance I got. My medical team arranged to file for a special grant because I never learned about the expense until I was informed about the prescription. The expense to me explains why doctors promote "wait & watch" because a prescription could be beyond most people's budget?
Ibrutinib is a capsule and I have been on it for 3 years. I have been on 3 capsules and it gave me diarrhea 6 times a day so they moved me back to 2 capsules a day even though due to my weight I should be on 3 capsules. I am actively trying to loose weight now